Tickborne infections as a cause of nonspecific febrile illness in Wisconsin

Clinical Infectious Diseases

Volumn 32, Issue 10, 2001, Pages 1434-1439

  Belongia, Edward A ^a   Reed, Kurt D ^a   Mitchell, Paul D ^a   Mueller Rizner, Nancy ^a   Vandermause, Mary ^a   Finkel, Michael F ^b   Kazmierczak, James J ^c  

^a MARSHFIELD CLINIC   (United States)

^b Midelfort Clinic   (United States)

^c University of Wisconsin Madison   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BABESIA MICROTI; BABESIOSIS; BORRELIA BURGDORFERI; CHILD; EHRLICHIA; FEMALE; FEVER; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; TICK BITE; TICK BORNE DISEASE; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; BORRELIA; BORRELIA BURGDORFERI GROUP; BORRELIA INFECTIONS; CHILD; CHILD, PRESCHOOL; EHRLICHIA; EHRLICHIOSIS; FEMALE; FEVER; HUMANS; LYME DISEASE; MALE; MIDDLE AGED; TICK-BORNE DISEASES; WISCONSIN;

EID: 0035873060     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/320160     Document Type: Article

References (41)

1. Tick-borne diseases in the United States
2. Lyme disease: United States, 1996
3. Early Lyme disease: A flu-like illness without erythema migrans
4. Longitudinal assessment of the clinical and epidemiological features of Lyme disease in a defined population
5. Rapid emergence of a focal epidemic of Lyme disease in coastal Massachusetts
6. Babesiosis in Wisconsin: A new focus of disease transmission
7. Life-threatening babesiosis in a woman from Wisconsin
8. Babesiosis
9. Human babesiosis in New York State: An epidemiological description of 136 cases
10. Persistent parasitemia after acute babesiosis
11. Human babesiosis on Nantucket Island: Evidence for self-limited and subclinical infections
12. Babesiosis: An underdiagnosed disease of children
13. Babesiosis in Wisconsin: A potentially fatal disease
14. Infection with a Babesia-like organism in northern California
15. A fatal case of babesiosis in Missouri: Identification of another piroplasm that infects humans
16. Human granulocytic ehrlichiosis in the upper Midwest United States: A new species emerging?
17. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease
18. Clinical and laboratory characteristics of human granulocytic ehrlichiosis
19. Human granulocytic ehrlichiosis: A case series from a medical center in New York state
20. Statewide surveillance for ehrlichiosis: Connecticut and New York, 1994-1997
21. Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle
22. Ecology of Ixodes dammini-borne human babesiosis and Lyme disease
23. Seasonal prevalence of Borrelia burgdorferi in natural populations of white-footed mice, Peromyscus leucopus
24. Prevalence of the rickettsial agent of human granulocytic ehrlichiosis in ticks from a hyperendemic focus of Lyme disease
25. Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis
26. Concurrent Lyme disease and babesiosis: Evidence for increased severity and duration of illness
27. Coinfection with Babesia microti and Borrelia burgdorferi in a western Wisconsin resident
28. Cosegregation of a novel Bartonella species with Borrelia burgdorferi and Babesia microti in Peromyscus leucopus
29. Lyme disease in Wisconsin: 1997 morbidity, serologic testing practices, and geographic distribution of the vector tick
30. Comparison of four immunoserologic assays for detection of antibodies to Borrelia burgdorferi in patients with culture-positive erythema migrans
31. Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota
32. Recommendations for test performance and interpretation from the 2d National Conference on Serologic Diagnosis of Lyme Disease
33. Ixodes dammini as a potential vector of human granulocytic ehrlichiosis
34. How close is close: 16S rRNA sequence identity may not be sufficient to guarantee species identity
35. Universal bacterial 16S rRNA amplification and sequencing
36. Case definitions for infectious conditions under public health surveillance
37. Isolation of Borrelia burgdorferi from the blood of seven patients with Lyme disease
38. Primary isolation of Ehrlichia chaffeensis from patients with febrile illnesses: Clinical and molecular characteristics
39. Surveillance for Lyme disease United States, 1992-98
40. Clinical and epidemiological features of early Lyme disease and human granulocytic ehrlichiosis in Wisconsin
41. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant